Jaya Biosciences, operating as a privately held life sciences company in the pre-clinical stage, is dedicated to the development of gene therapies targeting the central nervous system (CNS) for genetically defined neurodegenerative diseases such as Alzheimer's, Parkinson's, and frontotemporal dementia. The foundation of Jaya's platform stems from a pioneering discovery: individuals carrying loss-of-function mutations in genes ...
Jaya Biosciences, operating as a privately held life sciences company in the pre-clinical stage, is dedicated to the development of gene therapies targeting the central nervous system (CNS) for genetically defined neurodegenerative diseases such as Alzheimer's, Parkinson's, and frontotemporal dementia. The foundation of Jaya's platform stems from a pioneering discovery: individuals carrying loss-of-function mutations in genes responsible for lysosomal enzymes exhibit a heightened susceptibility to neurodegeneration, including the early onset of symptoms.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.